| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/15/2004 | EP1456411A2 Methods of detecting modification of genetic material |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456401A2 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 09/15/2004 | EP1456400A2 Modulating insulin receptor signaling through targeting facl |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456355A2 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1455900A1 Methods of treating bacterial infections in dogs and cats |
| 09/15/2004 | EP1455847A1 Feminine care products for the delivery of therapeutic substances |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455836A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 09/15/2004 | EP1455831A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 09/15/2004 | EP1455830A1 Selective anesthetic agents and methods of identifying the same |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455799A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 09/15/2004 | EP1455795A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 09/15/2004 | EP1455794A2 PHARMACEUTICAL COMPOSITION COMPRISING A ClC-2 CHANNEL OPENER |
| 09/15/2004 | EP1455793A2 Antidiabetic formulation and method |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455783A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
| 09/15/2004 | EP1455780A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455770A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455759A2 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 09/15/2004 | EP1455744A2 Cosmetic and/or dermatological active ingredient combination |
| 09/15/2004 | EP1455734A1 Compositions comprising phenyl-glycine derivatives |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455697A1 Vaginal delivery of drugs |
| 09/15/2004 | EP1455603A1 Stimulation of in vivo production of proteins with formulation comprising leucine |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1401421A4 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 09/15/2004 | EP1322325A4 Inhibiting hepatitis c virus processing and replication |
| 09/15/2004 | EP1282425A4 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 09/15/2004 | EP1173210B1 Contraceptive compositions containing antiprogestinic and progestinic |
| 09/15/2004 | EP1140077B1 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |
| 09/15/2004 | EP1001774B1 Use of phospholamban inhibitors for increasing coronary flow |
| 09/15/2004 | EP0983054B1 Hair growth compositions and uses |
| 09/15/2004 | EP0941082B1 New use for 1,3-propanediol derivatives |
| 09/15/2004 | EP0857018B1 Betulinic acid derivatives and uses therefor |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0710109B1 Method for identifying a PDE IV inhibitor |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | CN1529759A Modular transfection system |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same |
| 09/15/2004 | CN1529620A Otic microbial compositions for treating animal with raptured tympanic membrane |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529618A Induction of tolerance |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529614A Method of reducing side effects of chemotherapy in cancer patient |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529612A Targeted delivery of drugs for treatment of viral infections |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1529605A Method employing and compositions containing defined oxidized phospholipids for preventing and breating atherosclerosis |
| 09/15/2004 | CN1529600A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses |
| 09/15/2004 | CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage |
| 09/15/2004 | CN1529592A Body fat level controllers |
| 09/15/2004 | CN1528460A Complex local medicine for mainly treating oral ulcer |
| 09/15/2004 | CN1528334A Use of anthracene-ring derivatives for preparing medicine to treat brain tumor |
| 09/15/2004 | CN1528315A Method for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166651C Anti-inflammatory and antineoplastic R-bis or glycophenylpropane isoselenazole substituted compound |
| 09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/15/2004 | CN1166361C Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/14/2004 | US6790960 Compounds |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered |
| 09/14/2004 | US6790853 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 09/14/2004 | US6790849 Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790626 Comprises preference for pyrimidine nucleotides (uridine triphosphate) over purine nucleotides; for determining ligand binding, detecting expression, drug screening, treatment |
| 09/14/2004 | US6790465 Composition and method for treating snoring |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine) |
| 09/14/2004 | CA2073113C Conjugates |
| 09/12/2004 | CA2458761A1 Prosthesis with sustained release analgesic |
| 09/11/2004 | CA2458288A1 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| 09/10/2004 | WO2004077055A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | WO2004076369A2 Antimicrobial active borosilicate glass |
| 09/10/2004 | WO2004076349A1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto |
| 09/10/2004 | WO2004075907A2 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 09/10/2004 | WO2004075903A1 Combined use of ribavirin and interferon beta in demyelinating diseases |
| 09/10/2004 | WO2004075901A2 Compositon for increasing levels of hormones and a method for preparation of said composition |
| 09/10/2004 | WO2004075874A1 Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides |
| 09/10/2004 | WO2004075857A2 Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions |